Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel for Brain Metastases in Breast or Lung Cancer
NCT02166658Phase 2Terminated
- Sponsor
- AIO-Studien
- Start
- Aug 2015
- Primary completion
- Apr 2017
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in breast cancer, lung cancer, sponsored by AIO-Studien. Started Aug 2015; status: terminated.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
breast cancerlung cancer
Beyond the preview
Go deeper on NCT02166658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166658.